Effects of coronary vasodilators on coronary circulation in the sclerotic heart disease.
D000328:Adult; D000368:Aged; D001784:Blood Gas Analysis; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000187:drug effects; D010208:Papaverine / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects*; D013806:Theophylline / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D004176:Dipyridamole; D013806:Theophylline; D010208:Papaverine; D011299:Prenylamine